Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic Disease and Therapy Review: Prostate Cancer Timely Data Resources, Inc., Jan 2007, Pages: 12   Description     Table of Contents        Enquire before Buying    Send to a Friend   The Prostate Cancer Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis and staging, and an overview of treatments for localized disease, locally and regionally advanced disease, and metastatic disease. Dosing information is provided for LHRH agonists, anti-androgens, and chemotherapy. General information on sales of prostate cancer therapies worldwide, as well as for LHRH agonists and anti-androgens is provided. Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by a senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided. Customers who bought this item also bought Stakeholder Insight: Prostate Cancer Treatment and Commercial Issues Prostate Cancer Opinion Leader Forum, 2002 Stakeholder Insight: Metastatic And Hormone Refractory Prostate cancer Drugs of Tomorrow 2000: Prostate Cancer - Hormonals and Beyond Prostate Cancer - A Prostrate Market Waiting For Innovations Stakeholder Insight: Local and Locally Advanced Prostate Cancer Treatment Algorithms 2001: Prostate Cancer Stakeholder Insight: Prostate Cancer Treatment in the USA

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster